Lumida
/RCEL
⌘K
AVITA Medical Inc

AVITA Medical Inc

RCEL
$5.10USD+2.41%+0.12 today

MARKET CAP

157.0M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$7

AI Summary

Stalk
TrimMedium

RCEL remains in a sustained Stage 4 decline with persistent lower highs and lower lows and price below all key moving averages. Oversold conditions at current levels increase the risk of a bounce, so under the speculative strategy we defer selling to rallies into resistance around the EMAs to ensure asymmetric entry.

  • Q1 2026 revenue of $19.3M (+4% YoY, +10% sequential) signals top‐line recovery
  • Operating expenses down 11% YoY to $24.5M, boosting cost discipline
  • Q1 net loss of $10.6M indicates ongoing unprofitability
Full analysis →
Insider Trades26 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 12, 2026BuyRCELDavid D O'TooleCFO2,000$3.97$157.0M-28.37%+58.39%$7.9K+1.33%Trim
May 29, 2026BuyRCELCary Guy VancePresident and CEO5,000$3.05$157.0M-28.37%+58.39%$15.3K+13.98%Trim
May 29, 2026BuyRCELDavid D O'TooleCFO5,000$3.05$157.0M-28.37%+58.39%$15.3K+3.43%Trim
May 20, 2026BuyRCELDavid D O'TooleCFO2,000$4.26$157.0M-28.37%+58.39%$8.5K+1.39%Trim
May 19, 2026BuyRCELDavid D O'TooleCFO2,000$4.24$157.0M-28.37%+58.39%$8.5K+1.41%Trim
Mar 11, 2026BuyRCELDavid D O'TooleCFO1,800$4.78$157.0M-28.37%+58.39%$8.6K+1.28%Trim
Feb 19, 2026BuyRCELDavid D O'TooleCFO3,000$4.15$157.0M-28.37%+58.39%$12.5K+2.19%Trim
Aug 26, 2025BuyRCELDavid D O'TooleCFO2,000$4.52$157.0M-28.37%+58.39%$9.0K+6.74%Trim
Aug 12, 2025BuyRCELDavid D O'TooleCFO2,000$4.81$157.0M-28.37%+58.39%$9.6K+7.23%Trim
May 30, 2025BuyRCELDavid D O'TooleCFO1,923$4.78$157.0M-28.37%+58.39%$9.2K+7.47%Trim
Feb 20, 2025BuyRCELDavid D O'TooleCFO1,000$9.90$157.0M-28.37%+58.39%$9.9K+4.04%Trim
Feb 19, 2025BuyRCELDavid D O'TooleCFO1,000$10.25$157.0M-28.37%+58.39%$10.3K+4.21%Trim
Nov 29, 2024BuyRCELDavid D O'TooleCFO1,760$10.40$157.0M-28.37%+58.39%$18.3K+2.59%Trim
May 31, 2024BuyRCELDonna ShiromaGeneral Counsel2,225$8.17$157.0M-28.37%+58.39%$18.2K+5.09%Trim
May 30, 2024BuyRCELDavid D O'TooleCFO3,240$8.39$157.0M-28.37%+58.39%$27.2K+5.62%Trim
Feb 28, 2024BuyRCELDavid D O'TooleCFO1,250$17.39$157.0M-28.37%+58.39%$21.7K+3.48%Trim
Dec 26, 2023SellRCELJames CorbettCEO1,445$13.29$157.0M-28.37%+58.39%$19.2K-11.09%Trim
Dec 12, 2023BuyRCELDavid D O'TooleCFO950$12.45$157.0M-28.37%+58.39%$11.8K+5.75%Trim
Nov 30, 2023BuyRCELDonna ShiromaGeneral Counsel1,469$9.06$157.0M-28.37%+58.39%$13.3K+1.03%Trim
Nov 30, 2023BuyRCELDavid D O'TooleCFO1,534$9.59$157.0M-28.37%+58.39%$14.7K+4.94%Trim
Nov 21, 2023BuyRCELDavid D O'TooleCFO2,000$10.28$157.0M-28.37%+58.39%$20.6K+7.41%Trim
Nov 16, 2023BuyRCELDavid D O'TooleCFO2,000$12.30$157.0M-28.37%+58.39%$24.6K+8.70%Trim
Nov 14, 2023BuyRCELDavid D O'TooleCFO2,000$13.06$157.0M-28.37%+58.39%$26.1K+10.53%Trim
Aug 21, 2023SellRCELDonna ShiromaGeneral Counsel4,193$15.84$157.0M-28.37%+58.39%$66.4K-9.03%Trim
Aug 16, 2023BuyRCELDavid D O'TooleCFO2,000$17.05$157.0M-28.37%+58.39%$34.1K+13.33%Trim
Aug 15, 2023BuyRCELDavid D O'TooleCFO5,000$17.93$157.0M-28.37%+58.39%$89.6K+25.00%Trim